AVTX
Avalo Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +6.1% ·
aandelenstroom +26.7% ·
netto nieuwe posities +5.7%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 51 | +13 | 31.74M | $586.58M | +19 | −6 |
| Q1 2026 | 38 | +3 | 12.35M | $184.22M | +7 | −4 |
| Q4 2025 | 35 | +2 | 8.20M | $148.88M | +2 | n/a |
| Q3 2025 | 13 | +7 | 3.14M | $39.85M | +7 | n/a |
| Q2 2025 | 4 | +1 | 446.19K | $2.23M | +1 | n/a |
| Q1 2025 | 1 | -1 | 107.81K | $864,389 | n/a | −1 |
| Q4 2024 | 2 | +1 | 120.18K | $892,907 | +1 | n/a |
| Q3 2024 | 1 | +1 | 10.11K | $95,649 | +1 | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 804.08K | +16.1% | $14.60M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 2 | Millennium Management ✦ | 659.98K | +380.2% | $11.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Point72 Asset Management ✦ | 627.50K | -40.5% | $11.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Bank Of America Corp /De/ | 621.35K | n/a | $11.28M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Adage Capital Partners ✦ | 550.00K | +112.5% | $9.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 507.55K | +806.2% | $9.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 7 | UBS Group AG | 477.82K | n/a | $8.68M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Jennison Associates Llc | 475.62K | n/a | $8.64M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Balyasny Asset Management L.P. | 439.31K | n/a | $7.98M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 419.49K | -12.9% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 11 | BlackRock ✦ (passief) | 289.57K | +87.7% | $5.26M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 12 | Morgan Stanley ✦ | 264.91K | +2648970.0% | $4.81M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 13 | Fidelity (FMR) ✦ | 220.30K | Nieuw | $4.00M | 0.0% | New | 1 | SEC ↗ |
| 14 | Ameriprise Financial Inc | 217.97K | n/a | $3.96M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Susquehanna International Group, Llp | 210.99K | n/a | $3.83M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Bnp Paribas Financial Markets | 197.75K | n/a | $3.59M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Jane Street Group, Llc | 178.85K | n/a | $3.25M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 18 | Geode Capital Management ✦ (passief) | 166.15K | +59.5% | $3.02M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 19 | Deutsche Bank Ag\ | 150.00K | n/a | $2.72M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 148.24K | +201.0% | $2.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Barclays Plc | 105.81K | n/a | $1.92M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 22 | Aberdeen Group plc | 95.43K | n/a | $1.73M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passief) | 79.25K | +74.4% | $1.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 65.31K | Nieuw | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 25 | Qube Research & Technologies Ltd | 64.46K | n/a | $1.17M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 44.43K | +1312.3% | $806,867 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Squarepoint Ops LLC | 40.85K | n/a | $741,909 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Northern Trust Corp | 32.20K | n/a | $584,825 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Renaissance Technologies ✦ | 18.30K | -81.5% | $332,328 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Envestnet Asset Management Inc | 16.04K | n/a | $291,268 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Belvedere Trading LLC | 4.53K | n/a | $82,192 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Us Bancorp \De\ | 2.73K | n/a | $49,631 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 33 | Citigroup Inc | 1.14K | n/a | $20,757 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Osaic Holdings, Inc. | 1 | n/a | $18 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Group One Trading Llc | 1 | n/a | $18 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Fidelity (FMR) | $4.00M | 0.0% |
| Goldman Sachs Group | $1.19M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 96 houders, 30.91M aandelen, $428.51M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 12.39K aand · $202,437
Officer · 10.19K aand · $179,457
Officer · 679 aand · $13,580
Officer · 31.03K aand · $622,324
Officer · 37.95K aand · $753,333
Officer · 3.75K aand · $74,762
Officer · 1.00K aand · $20,000
Officer · 2.65K aand · $52,012
Officer · 679 aand · $13,580
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie